Synchronous lung adenocarcinoma in situ and type B2-B3 thymoma in a frozen hemithorax: a case report and multidisciplinary approach - Takeaways - MDSpire

Synchronous lung adenocarcinoma in situ and type B2-B3 thymoma in a frozen hemithorax: a case report and multidisciplinary approach

  • By

  • Chenglin Fan

  • Gaoyuan Sang

  • Ziyi Liang

  • Jialin Yu

  • Sixuan Song

  • Jingjun Zhu

  • Zhengzhe Xu

  • May 15, 2026

Share

  • 1

    Synchronous primary lung adenocarcinoma in situ and type B2-B3 thymoma are rare, complicating diagnosis and management.

  • 2

    PET/CT can mislead diagnosis due to hypermetabolic activity from inflammation, mimicking aggressive malignancies.

  • 3

    A multidisciplinary team approach is crucial for high-risk patients to avoid misdiagnosis and unnecessary surgical interventions.

  • 4

    The patient underwent successful uniportal VATS for resection despite extensive pleural adhesions from prior tuberculosis.

  • 5

    Final pathology revealed a small adenocarcinoma in situ obscured by organizing pneumonia, highlighting diagnostic challenges.

Original Source(s)

Synchronous lung adenocarcinoma in situ and type B2-B3 thymoma in a frozen hemithorax: a case report and multidisciplinary approach

  • by Chenglin Fan, Gaoyuan Sang, Ziyi Liang, Jialin Yu, Sixuan Song, Jingjun Zhu, Zhengzhe Xu

  • May 15, 2026

Related Content

Does the Timing of Immunotherapy Administration Affect Outcomes in Advanced Cancers?

A systematic review and meta-analysis found that early time-of-day immunotherapy was associated with improved survival outcomes in patients with advanced cancers, with the association appearing to be ...

Combination Enzalutamide and Radium-223 Extends Overall Survival in Bone-Dominant mCRPC

In the final analysis of the phase III EORTC 1333/PEACE-3 trial, with a median follow-up of 58 months, the addition of radium-223 to the androgen receptor inhibitor enzalutamide significantly prolonge...

Lack of Research in Understanding the Global Population of Childhood Cancer Survivors Leads to Gaps in Care and Cures

Each year, globally, about 400,000 children and adolescents aged between 0 and 19 years are diagnosed with cancer; over 100,000 die from the disease, with most of those cases, over 80%, and deaths occ...